Role of PDGFRα-mediated signalling in anoikis resistance in glioblastoma: in vitro study

No abstract is available for this paper.

• Publication year

  2025

• Venue

  In Vitro Cellular & Developmental Biology - Animal

• Publication date

  2025-07-21

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s11626-025-01075-6PMID 40691398
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Involvement of PDGFR‐integrin interactions in the regulation of anoikis resistance in glioblastoma progression

  2024cited by this paper
• Lipid rafts, caveolae, and epidermal growth factor receptor family: friends or foes?

  2024cited by this paper
• Glioblastoma multiforme influence on the elemental homeostasis of the distant organs: the results of inter-comparison study carried out with TXRF method

  2024cited by this paper
• Integrated single-cell multiomics reveals novel immune candidate markers for post-traumatic coagulopathy

  2023cited by this paper
• Prospective Evaluation of MGMT-Promoter Methylation Status and Correlations with Outcomes to Temozolomide-Based Chemotherapy in Well-Differentiated Neuroendocrine Tumors

  2023cited by this paper
• Regulation of anoikis by extrinsic death receptor pathways

  2023cited by this paper
• Antioxidant mechanisms of mesenchymal stem cells and their therapeutic potential in vitiligo

  2023cited by this paper
• New insights about the PDGF/PDGFR signaling pathway as a promising target to develop cancer therapeutic strategies.

  2023cited by this paper
• Roles of STAT3 in the pathogenesis and treatment of glioblastoma

  2023cited by this paper
• The role of lipids in cancer progression and metastasis.

  2022cited by this paper
• Anoikis resistance in diffuse glioma: The potential therapeutic targets in the future

  2022cited by this paper
• Identification and validation of an anoikis-associated gene signature to predict clinical character, stemness, IDH mutation, and immune filtration in glioblastoma

  2022cited by this paper
• Anoikis-Associated Lung Cancer Metastasis: Mechanisms and Therapies

  2022cited by this paper
• Platelet-derived growth factor (PDGF) cross-signaling via non-corresponding receptors indicates bypassed signaling in colorectal cancer

  2022cited by this paper
• Outcomes in Elderly Patients with Glioblastoma Multiforme Treated with Short-Course Radiation Alone Compared to Short-Course Radiation and Concurrent and Adjuvant Temozolomide Based on Performance Status and Extent of Resection

  2021cited by this paper
• Receptor tyrosine kinases as druggable targets in glioblastoma: Do signaling pathways matter?

  2021cited by this paper
• Mechanotransduction at the Plasma Membrane-Cytoskeleton Interface

  2021cited by this paper
• Role of PI3K-AKT-mTOR Pathway as a Pro-Survival Signaling and Resistance-Mediating Mechanism to Therapy of Prostate Cancer

  2021cited by this paper
• Mechanisms for Modulating Anoikis Resistance in Cancer and the Relevance of Metabolic Reprogramming

  2021cited by this paper
• Lipid raft involvement in signal transduction in cancer cell survival, cell death and metastasis

  2021cited by this paper
• Characterization of SOX2, OCT4 and NANOG in Ovarian Cancer Tumor-Initiating Cells

  2020cited by this paper
• The emerging complexity of PDGFRs: activation, internalization and signal attenuation.

  2020cited by this paper
• Lipid rafts as signaling hubs in cancer cell survival/death and invasion: implications in tumor progression and therapy

  2020cited by this paper
• Cell adhesion in cancer: Beyond the migration of single cells

  2020cited by this paper
• Pivotal Role of STAT3 in Shaping Glioblastoma Immune Microenvironment

  2019cited by this paper
• Integrin-EGFR interaction regulates anoikis resistance in colon cancer cells

  2019cited by this paper
• Mechanisms of receptor tyrosine kinase activation in cancer

  2018cited by this paper
• Modulation of key lipid raft constituents in primary rat hepatocytes by fumonisin B1 - Implications for cancer promotion in the liver.

  2018cited by this paper
• Insights into molecular therapy of glioma: current challenges and next generation blueprint

  2017cited by this paper
• Current Standards of Care in Glioblastoma Therapy

  2017cited by this paper
• Lipid rafts in immune signalling: current progress and future perspective

  2016cited by this paper
• The Sigma-1 Receptor as a Pluripotent Modulator in Living Systems.

  2016cited by this paper
• PI3K/Akt/mTOR signaling pathway in cancer stem cells: from basic research to clinical application.

  2015cited by this paper
• Cholesterol depletion using methyl-β-cyclodextrin.

  2015cited by this paper
• Epidemiologic and Molecular Prognostic Review of Glioblastoma

  2014cited by this paper
• Tenascin-C-derived Peptide TNIIIA2 Highly Enhances Cell Survival and Platelet-derived Growth Factor (PDGF)-dependent Cell Proliferation through Potentiated and Sustained Activation of Integrin α5β1

  2014cited by this paper
• PDGF receptor alpha inhibition induces apoptosis in glioblastoma cancer stem cells refractory to anti-Notch and anti-EGFR treatment

  2014influential reference
• Platelet-derived growth factor in glioblastoma—driver or biomarker?

  2014cited by this paper
• Anoikis molecular pathways and its role in cancer progression.

  2013cited by this paper
• Effect of ligand density, receptor density, and nanoparticle size on cell targeting.

  2013cited by this paper
• Current Trends in Targeted Therapies for Glioblastoma Multiforme

  2012cited by this paper
• Anoikis Resistance: An Essential Prerequisite for Tumor Metastasis

  2012cited by this paper
• Autocrine PDGF stimulation in malignancies

  2012cited by this paper
• The Role of Lipid Rafts in Cancer Cell Adhesion and Migration

  2011cited by this paper
• Inhibition of the JAK-2/STAT3 signaling pathway impedes the migratory and invasive potential of human glioblastoma cells

  2011cited by this paper
• Agrin triggers the clustering of raft‐associated acetylcholine receptors through actin cytoskeleton reorganization

  2011cited by this paper
• Platelet-Derived Growth Factor (PDGF)/PDGF Receptors (PDGFR) Axis as Target for Antitumor and Antiangiogenic Therapy

  2010cited by this paper
• Real-time monitoring of membrane cholesterol reveals new insights into epidermal differentiation.

  2010cited by this paper
• Regulation of Platelet-derived Growth Factor Receptor Function by Integrin-associated Cell Surface Transglutaminase*

  2009cited by this paper
• Lipid rafts, cholesterol, and the brain.

  2008cited by this paper
• PDGFRs are critical for PI3K/Akt activation and negatively regulated by mTOR.

  2007cited by this paper
• Elevated levels of cholesterol-rich lipid rafts in cancer cells are correlated with apoptosis sensitivity induced by cholesterol-depleting agents.

  2006cited by this paper
• Lipid Rafts and Integrin Activation Regulate Oligodendrocyte Survival

  2004cited by this paper
• Oncogenic derivatives of platelet-derived growth factor receptors.

  2004cited by this paper
• PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo.

  2001cited by this paper
• Oncogenic kinase signalling

  2001cited by this paper
• Functional rafts in cell membranes

  1997cited by this paper
• Supratentorial malignant glioma: patterns of recurrence and implications for external beam local treatment.

  1992cited by this paper

• No citing papers are available for this paper.